Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00861263 · ClinicalTrials.gov registry record · NA
The Clinical Utility of Overtube Use at the Time of Endoscopy
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
NCT00861263: Completed NA study, sponsored by University of Florida.
NCT00861263 is a NA study that has completed, run by University of Florida. The registered enrollment target is 193 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00861263, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
Study Summary
Endoscopy has become a vital part of the gastroenterologist's evaluation and treatment of disorders involving the gastrointestinal (GI) tract. The small bowel is an area of the GI tract, which can prove difficult to visualize during an endoscopy specifically designed to evaluate it, termed enteroscopy. Thus, the FDA has approved overtubes, such as the Endo-Ease® spiral overtube (Spirus Medical, Inc.) or EnteroPro® balloon overtube (Olympus Medical, Inc.), to facilitate passage of the endoscope through the GI tract. The aims of the study are to evaluate the efficiency of an overtube system for visualization of small bowel. The hypothesis is that this will permit more complete and efficient evaluation of the small intestine.
Primary Outcome
The number of patients that had persistent or recurrent GI bleeding after spiral enteroscopy.
Interventions
- DEVICE overtube use during enteroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2007-06 |
| Est. Completion | 2012-10 |
| Phase | NA |
What the finished NCT00861263 record still lists
NCT00861263 is an interventional study that assigns participants to a tested intervention. The registered 193 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which overtube use during enteroscopy is the first listed.
NCT00861263 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00861263 about?
NCT00861263 is a clinical study titled "The Clinical Utility of Overtube Use at the Time of Endoscopy". Endoscopy has become a vital part of the gastroenterologist's evaluation and treatment of disorders involving the gastrointestinal (GI) tract. The small bowel is an area of the GI tract, which can prove difficult to visualize during an endoscopy specifically designed to evaluate it, termed enterosco...
What is the current status of trial NCT00861263?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2007-06. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00861263?
The interventions under investigation include: overtube use during enteroscopy (DEVICE).
Who is sponsoring clinical trial NCT00861263?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00861263's enrollment target sits among peer trials
193 569th of 2000 higher than 1,431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06226220 · 193 participants · NA
Percutaneous Nerve Evaluation Trial Time
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia